{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:56:11Z","timestamp":1791849371080,"version":"4.3.4"},"reference-count":41,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,20]]},"DOI":"10.20945\/2359-4292-2023-0101","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:15:14Z","timestamp":1716394514000},"source":"Crossref","is-referenced-by-count":4,"title":["Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy"],"prefix":"10.20945","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-2674","authenticated-orcid":false,"given":"Zhenxing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8168-0233","authenticated-orcid":false,"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0459-1923","authenticated-orcid":false,"given":"Bingqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-4432","authenticated-orcid":false,"given":"Wanlu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4340-6841","authenticated-orcid":false,"given":"Pengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-8430","authenticated-orcid":false,"given":"Xueyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7179-0044","authenticated-orcid":false,"given":"Min","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0157-1545","authenticated-orcid":false,"given":"Jiangfeng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"4","key":"key20240522121506_B1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2002-36707","article-title":"Hypogonadotropic hypogonadism","volume":"20","author":"Silveira","year":"2002","unstructured":"Silveira LF, MacColl GS, Bouloux PM. Hypogonadotropic hypogonadism. Semin Reprod Med. 2002 Nov;20(4):327-38. doi: 10.1055\/s-2002-36707.","journal-title":"Semin Reprod Med"},{"issue":"4","key":"key20240522121506_B2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0889-8529(05)70039-6","article-title":"Hypogonadotropic hypogonadism","volume":"27","author":"Hayes","year":"1998","unstructured":"Hayes FJ, Seminara SB, Crowley WF Jr. Hypogonadotropic hypogonadism. Endocrinol Metab Clin North Am. 1998 Dec;27(4):739-63, vii. doi: 10.1016\/s0889-8529(05)70039-6.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl 1(Suppl 1)","key":"key20240522121506_B3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6061\/clinics\/2013(Sup01)09","article-title":"Hypogonadotropic hypogonadism revisited","volume":"68","author":"Fraietta","year":"2013","unstructured":"Fraietta R, Zylberstejn DS, Esteves SC. Hypogonadotropic hypogonadism revisited. Clinics (Sao Paulo). 2013;68 Suppl 1(Suppl 1):81-8. doi: 10.6061\/clinics\/2013(sup01)09.","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"key20240522121506_B4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1530\/eje.0.1390298","article-title":"Pulsatile GnRH or human chorionic gonadotropin\/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases","volume":"139","author":"B\u00fcchter","year":"1998","unstructured":"B\u00fcchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin\/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol. 1998 Sep;139(3):298-303. doi: 10.1530\/eje.0.1390298.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key20240522121506_B5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ecl.2007.03.010","article-title":"Hypogonadotropic hypogonadism","volume":"36","author":"Layman","year":"2007","unstructured":"Layman LC. Hypogonadotropic hypogonadism. Endocrinol Metab Clin North Am. 2007 Jun;36(2):283-96. doi: 10.1016\/j.ecl.2007.03.010.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"key20240522121506_B6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/andr.262","article-title":"Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study","volume":"2","author":"Rastrelli","year":"2014","unstructured":"Rastrelli G, Corona G, Mannucci E, Maggi M. Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology. 2014;2(6):794-808. doi: 10.1111\/andr.262.","journal-title":"Andrology"},{"issue":"9","key":"key20240522121506_B7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrendo.2015.112","article-title":"Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment","volume":"11","author":"Boehm","year":"2015","unstructured":"Boehm U, Bouloux PM, Dattani MT, de Roux N, Dod\u00e9 C, Dunkel L, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015 Sep;11(9):547-64. doi: 10.1038\/nrendo.2015.112.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"key20240522121506_B8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1210\/er.2018-00116","article-title":"Clinical Management of Congenital Hypogonadotropic Hypogonadism","volume":"40","author":"Young","year":"2019","unstructured":"Young J, Xu C, Papadakis GE, Acierno JS, Maione L, Hietam\u00e4ki J, et al. Clinical Management of Congenital Hypogonadotropic Hypogonadism. Endocr Rev. 2019 Apr 1;40(2):669-710. doi: 10.1210\/er.2018-00116.","journal-title":"Endocr Rev"},{"issue":"6","key":"key20240522121506_B9","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4103\/1008-682X.193568","article-title":"Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism","volume":"19","author":"Mao","year":"2017","unstructured":"Mao JF, Liu ZX, Nie M, Wang X, Xu HL, Huang BK, et al. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism. Asian J Androl. 2017 Nov-Dec;19(6):680-5. doi: 10.4103\/1008-682X.193568.","journal-title":"Asian J Androl"},{"issue":"31","key":"key20240522121506_B10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016616","article-title":"Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism","volume":"98","author":"Lin","year":"2019","unstructured":"Lin J, Mao J, Wang X, Ma W, Hao M, Wu X. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism. Medicine (Baltimore). 2019 Aug;98(31):e16616. doi: 10.1097\/MD.0000000000016616.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"key20240522121506_B11","doi-asserted-by":"crossref","DOI":"10.1177\/1557988318818280","article-title":"The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men","volume":"13","author":"Zhang","year":"2019","unstructured":"Zhang L, Cai K, Wang Y, Ji W, Cheng Z, Chen G, et al. The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men. Am J Mens Health. 2019 Jan-Feb;13(1):1557988318818280. doi: 10.1177\/1557988318818280.","journal-title":"Am J Mens Health"},{"issue":"4","key":"key20240522121506_B12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1439-0272.1988.tb00687.x","article-title":"Successful GnRH treatment in a patient with Kallmann\u2019s syndrome, who previously failed HMG\/HCG treatment","volume":"20","author":"Berezin","year":"1988","unstructured":"Berezin M, Weissenberg R, Rabinovitch O, Lunenfeld B. Successful GnRH treatment in a patient with Kallmann\u2019s syndrome, who previously failed HMG\/HCG treatment. Andrologia. 1988 Jul-Aug;20(4):285-8. doi: 10.1111\/j.1439-0272.1988.tb00687.x.","journal-title":"Andrologia"},{"issue":"2","key":"key20240522121506_B13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/09513598809023623","article-title":"Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH)","volume":"2","author":"Blumenfeld","year":"1988","unstructured":"Blumenfeld Z, Makler A, Frisch L, Brandes JM. Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH). Gynecol Endocrinol. 1988 Jun;2(2):151-64. doi: 10.3109\/09513598809023623.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"key20240522121506_B14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJMoa066494","article-title":"Reversal of idiopathic hypogonadotropic hypogonadism","volume":"357","author":"Raivio","year":"2007","unstructured":"Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007 Aug 30;357(9):863-73. doi: 10.1056\/NEJMoa066494.","journal-title":"N Engl J Med"},{"key":"key20240522121506_B15","first-page":"1059","article-title":"[A review of WHO Laboratory Manual for the Examination and Processing of Human Semen","volume-title":"Zhonghua Nan Ke Xue","author":"Cao","year":"2011","unstructured":"Cao XW, Lin K, Li CY, Yuan CW. [A review of WHO Laboratory Manual for the Examination and Processing of Human Semen (5th edition)]. Zhonghua Nan Ke Xue. 2011 Dec;17(12):1059-63.","edition":"(5th edition)"},{"issue":"4","key":"key20240522121506_B16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4103\/aja.aja_88_19","article-title":"Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients","volume":"22","author":"Hao","year":"2020","unstructured":"Hao M, Nie M, Yu BQ, Gao YJ, Wang X, Ma WL, et al. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients. Asian J Androl. 2020 Jul-Aug;22(4):390-395. doi: 10.4103\/aja.aja_88_19.","journal-title":"Asian J Androl"},{"key":"key20240522121506_B17","doi-asserted-by":"crossref","first-page":"828697","DOI":"10.1155\/2014\/828697","article-title":"Macrophages and Leydig cells in testicular biopsies of azoospermic men","volume":"2014","author":"Golu\u017ea","year":"2014","unstructured":"Golu\u017ea T, Boscanin A, Cvetko J, Kozina V, Kosovi\u0107 M, Bernat MM, et al. Macrophages and Leydig cells in testicular biopsies of azoospermic men. Biomed Res Int. 2014;2014:828697. doi: 10.1155\/2014\/828697.","journal-title":"Biomed Res Int"},{"issue":"1","key":"key20240522121506_B18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1210\/endo-110-1-138","article-title":"The effects of chronic human chorionic gonadotropin treatment on Leydig cell function","volume":"110","author":"Risbridger","year":"1982","unstructured":"Risbridger GP, Robertson DM, de Kretser DM. The effects of chronic human chorionic gonadotropin treatment on Leydig cell function. Endocrinology. 1982 Jan;110(1):138-45. doi: 10.1210\/endo-110-1-138.","journal-title":"Endocrinology"},{"issue":"5","key":"key20240522121506_B19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/jcem-57-5-1041","article-title":"Development of anti-human chorionic gonadotropin antibodies in patients with hypogonadotropic hypogonadism. A study of four patients","volume":"57","author":"Claustrat","year":"1983","unstructured":"Claustrat B, David L, Faure A, Francois R. Development of anti-human chorionic gonadotropin antibodies in patients with hypogonadotropic hypogonadism. A study of four patients. J Clin Endocrinol Metab. 1983 Nov;57(5):1041-7. doi: 10.1210\/jcem-57-5-1041.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5587","key":"key20240522121506_B20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/264644a0","article-title":"hCG-induced decrease in availability of rat testis receptors","volume":"264","author":"Sharpe","year":"1976","unstructured":"Sharpe RM. hCG-induced decrease in availability of rat testis receptors. Nature. 1976 Dec 16;264(5587):644-6. doi: 10.1038\/264644a0.","journal-title":"Nature"},{"issue":"12","key":"key20240522121506_B21","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1016\/S0021-9258(17)34719-1","article-title":"Regulation of luteinizing hormone receptors and steroidogenesis in gonadotropin-desensitized leydig cells","volume":"253","author":"Cigorraga","year":"1978","unstructured":"Cigorraga SB, Dufau ML, Catt KJ. Regulation of luteinizing hormone receptors and steroidogenesis in gonadotropin-desensitized leydig cells. J Biol Chem. 1978 Jun 25;253(12):4297-304.","journal-title":"J Biol Chem"},{"issue":"5 Pt 1","key":"key20240522121506_B22","first-page":"E658","article-title":"Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone","volume":"254","author":"Spratt","year":"1988","unstructured":"Spratt DI, O\u2019Dea LS, Schoenfeld D, Butler J, Rao PN, Crowley WF Jr. Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol. 1988 May;254(5 Pt 1):E658-66. doi: 10.1152\/ajpendo.1988.254.5.E658.","journal-title":"Am J Physiol"},{"key":"key20240522121506_B23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fendo.2017.00274","article-title":"Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding","volume":"8","author":"Flanagan","year":"2017","unstructured":"Flanagan CA, Manilall A. Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding. Front Endocrinol (Lausanne). 2017 Oct 24;8:274. doi: 10.3389\/fendo.2017.00274.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"key20240522121506_B24","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0015-0282(16)54730-X","article-title":"Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism","volume":"56","author":"Schopohl","year":"1991","unstructured":"Schopohl J, Mehltretter G, von Zumbusch R, Eversmann T, von Werder K. Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil Steril. 1991 Dec;56(6):1143-50.","journal-title":"Fertil Steril"},{"issue":"20","key":"key20240522121506_B25","first-page":"1568","article-title":"[Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism]","volume":"95","author":"Huang","year":"2015","unstructured":"Huang B, Mao J, Xu H, Wang X, Liu Z, Nie M, et al. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism]. Zhonghua Yi Xue Za Zhi. 2015 May 26;95(20):1568-71.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"key20240522121506_B26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0015-0282(16)59720-9","article-title":"Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism","volume":"49","author":"Liu","year":"1988","unstructured":"Liu L, Chaudhari N, Corle D, Sherins RJ. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism. Fertil Steril. 1988 Feb;49(2):302-8. doi: 10.1016\/s0015-0282(16)59720-9.","journal-title":"Fertil Steril"},{"issue":"11","key":"key20240522121506_B27","doi-asserted-by":"crossref","first-page":"E1790","DOI":"10.1210\/jc.2013-2518","article-title":"Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism","volume":"98","author":"Dwyer","year":"2013","unstructured":"Dwyer AA, Sykiotis GP, Hayes FJ, Boepple PA, Lee H, Loughlin KR, et al. Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013 Nov;98(11):E1790-5. doi: 10.1210\/jc.2013-2518.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20240522121506_B28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2008.07.1742","article-title":"Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism","volume":"92","author":"Matsumoto","year":"2009","unstructured":"Matsumoto AM, Snyder PJ, Bhasin S, Martin K, Weber T, Winters S, et al. Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertil Steril. 2009 Sep;92(3):979-90. doi: 10.1016\/j.fertnstert.2008.07.1742.","journal-title":"Fertil Steril"},{"issue":"6","key":"key20240522121506_B29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4103\/aja.aja_6_19","article-title":"Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism","volume":"21","author":"Ortac","year":"2019","unstructured":"Ortac M, Hidir M, Salabas E, Boyuk A, Bese C, Pazir Y, et al. Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism. Asian J Androl. 2019 Nov-Dec;21(6):623-7. doi: 10.4103\/aja.aja_6_19.","journal-title":"Asian J Androl"},{"issue":"2","key":"key20240522121506_B30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/19396368.2014.994789","article-title":"Hormonal therapy (hCG and rhFSH) for infertile men with adult-onset idiopathic hypogonadotropic hypogonadism","volume":"61","author":"Kobori","year":"2015","unstructured":"Kobori Y, Suzuki K, Iwahata T, Shin T, Sato R, Nishio K, et al. Hormonal therapy (hCG and rhFSH) for infertile men with adult-onset idiopathic hypogonadotropic hypogonadism. Syst Biol Reprod Med. 2015 Apr;61(2):110-2. doi: 10.3109\/19396368.2014.994789.","journal-title":"Syst Biol Reprod Med"},{"issue":"1","key":"key20240522121506_B31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00439-020-02147-1","article-title":"Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease","volume":"140","author":"Cangiano","year":"2021","unstructured":"Cangiano B, Swee DS, Quinton R, Bonomi M. Genetics of congenital hypogonadotropic hypogonadism: peculiarities and phenotype of an oligogenic disease. Hum Genet. 2021 Jan;140(1):77-111. doi: 10.1007\/s00439-020-02147-1.","journal-title":"Hum Genet"},{"issue":"3","key":"key20240522121506_B32","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.21037\/tau.2020.03.33","article-title":"Genetics of hypogonadotropic hypogonadism","volume":"10","author":"Millar","year":"2021","unstructured":"Millar AC, Faghfoury H, Bieniek JM. Genetics of hypogonadotropic hypogonadism. Transl Androl Urol. 2021 Mar;10(3):1401-9. doi: 10.21037\/tau.2020.03.33.","journal-title":"Transl Androl Urol"},{"issue":"4","key":"key20240522121506_B33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jsxm.2020.01.011","article-title":"Correlations Among Genotype and Outcome in Chinese Male Patients with Congenital Hypogonadotropic Hypogonadism Under HCG Treatment","volume":"17","author":"Chen","year":"2020","unstructured":"Chen Y, Sun T, Niu Y, Wang D, Xiong Z, Li C, et al. Correlations Among Genotype and Outcome in Chinese Male Patients with Congenital Hypogonadotropic Hypogonadism Under HCG Treatment. J Sex Med. 2020 Apr;17(4):645-57. doi: 10.1016\/j.jsxm.2020.01.011.","journal-title":"J Sex Med"},{"key":"key20240522121506_B34","first-page":"8873532","article-title":"Clinical Characteristics and Spermatogenesis in Patients with Congenital Hypogonadotropic Hypogonadism Caused by FGFR1 Mutations","author":"Li","year":"2020","unstructured":"Li S, Zhao Y, Nie M, Ma W, Wang X, Ji W, et al. Clinical Characteristics and Spermatogenesis in Patients with Congenital Hypogonadotropic Hypogonadism Caused by FGFR1 Mutations. Int J Endocrinol. 2020 Nov 28;2020:8873532. doi: 10.1155\/2020\/8873532.","journal-title":"Int J Endocrinol"},{"issue":"3","key":"key20240522121506_B35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1210\/jc.2007-1168","article-title":"Kallmann\u2019s syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1\/KAL2 mutations","volume":"93","author":"Salenave","year":"2008","unstructured":"Salenave S, Chanson P, Bry H, Pugeat M, Cabrol S, Carel JC, et al. Kallmann\u2019s syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1\/KAL2 mutations. J Clin Endocrinol Metab. 2008 Mar;93(3):758-63. doi: 10.1210\/jc.2007-1168.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key20240522121506_B36","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s43032-021-00609-z","article-title":"Comparison of Clinical Characteristics and Spermatogenesis in CHH Patients Caused by PROKR2 and FGFR1 Mutations","volume":"28","author":"Li","year":"2021","unstructured":"Li S, Zhao Y, Nie M, Yang Y, Hao M, Mao J, et al. Comparison of Clinical Characteristics and Spermatogenesis in CHH Patients Caused by PROKR2 and FGFR1 Mutations. Reprod Sci. 2021 Nov;28(11):3219-27. doi: 10.1007\/s43032-021-00609-z.","journal-title":"Reprod Sci"},{"issue":"6","key":"key20240522121506_B37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/cen.13451","article-title":"Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism","volume":"87","author":"Wang","year":"2017","unstructured":"Wang Y, Gong C, Qin M, Liu Y, Tian Y. Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism. Clin Endocrinol (Oxf). 2017 Dec;87(6):757-66. doi: 10.1111\/cen.13451.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"key20240522121506_B38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/cen.13850","article-title":"Fertility induction in hypogonadotropic hypogonadal men","volume":"89","author":"Prior","year":"2018","unstructured":"Prior M, Stewart J, McEleny K, Dwyer AA, Quinton R. Fertility induction in hypogonadotropic hypogonadal men. Clin Endocrinol (Oxf). 2018 Dec;89(6):712-8. doi: 10.1111\/cen.13850.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"key20240522121506_B39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jc.2008-1648","article-title":"Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome","volume":"94","author":"Liu","year":"2009","unstructured":"Liu PY, Baker HW, Jayadev V, Zacharin M, Conway AJ, Handelsman DJ. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab. 2009 Mar;94(3):801-8. doi: 10.1210\/jc.2008-1648.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20240522121506_B40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/andr.12128","article-title":"Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults","volume":"4","author":"Rohayem","year":"2016","unstructured":"Rohayem J, Sinthofen N, Nieschlag E, Kliesch S, Zitzmann M. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults. Andrology. 2016 Jan;4(1):87-94. doi: 10.1111\/andr.12128.","journal-title":"Andrology"},{"issue":"7-8","key":"key20240522121506_B41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1515\/jpem-2012-0015","article-title":"Triptorelin depot stimulation test for central precocious puberty","volume":"26","author":"Strich","year":"2013","unstructured":"Strich D, Kvatinsky N, Hirsch HJ, Gillis D. Triptorelin depot stimulation test for central precocious puberty. J Pediatr Endocrinol Metab. 2013;26(7-8):631-4. doi: 10.1515\/jpem-2012-0015.","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T16:15:38Z","timestamp":1716394538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/pulsatile-gonadotropin-releasing-hormone-therapy-for-spermatogenesis-in-congenital-hypogonadotropic-hypogonadism-patients-who-had-poor-response-to-combined-gonadotropin-therapy\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":41,"alternative-id":["10.20945\/2359-4292-2023-0101"],"URL":"https:\/\/doi.org\/10.20945\/2359-4292-2023-0101","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e230101"}}